ASX Filings

Update Opthea Participates in November Investor Conferences

November 4, 2024

Opthea to Participate in November Investor Conferences

November 4, 2024

Quarterly Activities/Appendix 4C Cash Flow Report

October 31, 2024

Opthea Corporate Presentation - Oct 2024

October 28, 2024

Notice of Annual General Meeting/Proxy Form

October 16, 2024

Opthea Files Notice of Annual General Meeting

October 16, 2024

Opthea Wet AMD Program to be Presented at Innovate Retina

October 10, 2024

Opthea Appoints Chief Medical and Chief Financial Officer

October 8, 2024

Becoming a substantial holder

October 4, 2024

Opthea to participate in UBS Virtual Ophthalmology Day 2024

October 1, 2024